(Q39017231)

8 September 2017

Inhibition of CYP17A1 activity by resveratrol, piceatannol, and synthetic resveratrol analogs (English)

1 reference

8 September 2017

2 references

ChEBI release 2020-05-28

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Carmela Spatafora

2

0 references

Corrado Tringali

object named as

Corrado Tringali

series ordinal

3

0 references

Agneta Oskarsson

object named as

Agneta Oskarsson

series ordinal

1

0 references

author name string

Åsa Ohlsson Andersson

series ordinal

4

1 reference

8 September 2017

9 March 2014

1 reference

8 September 2017

1 reference

8 September 2017

74

1 reference

8 September 2017

8

1 reference

8 September 2017

839-851

1 reference

The phytoalexin resveratrol regulates the initiation of hypersensitive cell death in Vitis cell

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Resveratrol: French paradox revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

What is new for resveratrol? Is a new set of recommendations necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Biological activity of piceatannol: leaving the shadow of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Resveratrol--a prostate cancer chemopreventive agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

CYP17 inhibitors for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Resveratrol bioavailability and toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Biological effects on granulosa cells of hydroxylated and methylated resveratrol analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

The NCI-H295 cell line: a pluripotent model for human adrenocortical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindane in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Secretion of cortisol and aldosterone as a vulnerable target for adrenal endocrine disruption - screening of 30 selected chemicals in the human H295R cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells--underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Bioavailability of trans-resveratrol from red wine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Interaction of Resveratrol and Its Trimethyl and Triacetyl Derivatives with Biomembrane Models Studied by Differential Scanning Calorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Chemo-enzymatic preparation of resveratrol derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22801

Antiproliferative activity of methylated analogues of E- and Z-resveratrol.

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/PROS.22801

Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells

10 April 2024

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/PROS.22801

10 April 2024

Identifiers

DOI

10.1002/PROS.22801

1 reference

8 September 2017

1 reference

PubMed ID

24610083